Who Paid My Doc
Zynrelef
Drug Post Surgical Pain Relief
NDC 47426-302-02
General payments
$2,572,609
Research payments
$260,520
Through program year 2025, $2,572,609 in general payments and $260,520 in research payments were reported against Zynrelef (Post Surgical Pain Relief).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,049,981 | 3,915 |
| 2024 | General | $787,202 | 3,522 |
| 2024 | Research | $37,945 | 4 |
| 2023 | General | $735,426 | 3,876 |
| 2023 | Research | $222,575 | 45 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 90 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
11,313 general · 49 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.